1 Market Overview

1.1 Product Overview and Scope of Retinitis Pigmentosa Treatment

1.2 Classification of Retinitis Pigmentosa Treatment by Type

1.2.1 Overview: Global Retinitis Pigmentosa Treatment Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Retinitis Pigmentosa Treatment Revenue Market Share by Type in 2020

1.2.3 BNP-RP

1.2.4 Cenegermin

1.2.5 CPK-850

1.2.6 Cutamesine

1.2.7 FAB-111

1.2.8 Others

1.3 Global Retinitis Pigmentosa Treatment Market by Application

1.3.1 Overview: Global Retinitis Pigmentosa Treatment Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Homecare

1.4 Global Retinitis Pigmentosa Treatment Market Size & Forecast

1.5 Global Retinitis Pigmentosa Treatment Market Size and Forecast by Region

1.5.1 Global Retinitis Pigmentosa Treatment Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Retinitis Pigmentosa Treatment Market Size by Region, (2016-2021)

1.5.3 North America Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)

1.5.4 Europe Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)

1.5.6 South America Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Retinitis Pigmentosa Treatment Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Retinitis Pigmentosa Treatment Market Drivers

1.6.2 Retinitis Pigmentosa Treatment Market Restraints

1.6.3 Retinitis Pigmentosa Treatment Trends Analysis

2 Company Profiles

2.1 Astellas Pharma Inc.

2.1.1 Astellas Pharma Inc. Details

2.1.2 Astellas Pharma Inc. Major Business

2.1.3 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product and Solutions

2.1.4 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans

2.2 Caladrius Biosciences, Inc.

2.2.1 Caladrius Biosciences, Inc. Details

2.2.2 Caladrius Biosciences, Inc. Major Business

2.2.3 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product and Solutions

2.2.4 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Caladrius Biosciences, Inc. Recent Developments and Future Plans

2.3 Dompe Farmaceutici S.p.A.

2.3.1 Dompe Farmaceutici S.p.A. Details

2.3.2 Dompe Farmaceutici S.p.A. Major Business

2.3.3 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product and Solutions

2.3.4 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Dompe Farmaceutici S.p.A. Recent Developments and Future Plans

2.4 Genable Technologies Limited

2.4.1 Genable Technologies Limited Details

2.4.2 Genable Technologies Limited Major Business

2.4.3 Genable Technologies Limited Retinitis Pigmentosa Treatment Product and Solutions

2.4.4 Genable Technologies Limited Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Genable Technologies Limited Recent Developments and Future Plans

2.5 Genethon

2.5.1 Genethon Details

2.5.2 Genethon Major Business

2.5.3 Genethon Retinitis Pigmentosa Treatment Product and Solutions

2.5.4 Genethon Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Genethon Recent Developments and Future Plans

2.6 GenSight Biologics S.A.

2.6.1 GenSight Biologics S.A. Details

2.6.2 GenSight Biologics S.A. Major Business

2.6.3 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product and Solutions

2.6.4 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 GenSight Biologics S.A. Recent Developments and Future Plans

2.7 Grupo Ferrer Internacional, S.A.

2.7.1 Grupo Ferrer Internacional, S.A. Details

2.7.2 Grupo Ferrer Internacional, S.A. Major Business

2.7.3 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product and Solutions

2.7.4 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Grupo Ferrer Internacional, S.A. Recent Developments and Future Plans

2.8 ID Pharma Co., Ltd.

2.8.1 ID Pharma Co., Ltd. Details

2.8.2 ID Pharma Co., Ltd. Major Business

2.8.3 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Product and Solutions

2.8.4 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 ID Pharma Co., Ltd. Recent Developments and Future Plans

2.9 InFlectis BioScience

2.9.1 InFlectis BioScience Details

2.9.2 InFlectis BioScience Major Business

2.9.3 InFlectis BioScience Retinitis Pigmentosa Treatment Product and Solutions

2.9.4 InFlectis BioScience Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 InFlectis BioScience Recent Developments and Future Plans

2.10 International Stem Cell Corporation

2.10.1 International Stem Cell Corporation Details

2.10.2 International Stem Cell Corporation Major Business

2.10.3 International Stem Cell Corporation Retinitis Pigmentosa Treatment Product and Solutions

2.10.4 International Stem Cell Corporation Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 International Stem Cell Corporation Recent Developments and Future Plans

2.11 Ionis Pharmaceuticals, Inc.

2.11.1 Ionis Pharmaceuticals, Inc. Details

2.11.2 Ionis Pharmaceuticals, Inc. Major Business

2.11.3 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions

2.11.4 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Ionis Pharmaceuticals, Inc. Recent Developments and Future Plans

2.12 M's Science Corporation

2.12.1 M's Science Corporation Details

2.12.2 M's Science Corporation Major Business

2.12.3 M's Science Corporation Retinitis Pigmentosa Treatment Product and Solutions

2.12.4 M's Science Corporation Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 M's Science Corporation Recent Developments and Future Plans

2.13 Mimetogen Pharmaceuticals Inc.

2.13.1 Mimetogen Pharmaceuticals Inc. Details

2.13.2 Mimetogen Pharmaceuticals Inc. Major Business

2.13.3 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product and Solutions

2.13.4 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Mimetogen Pharmaceuticals Inc. Recent Developments and Future Plans

2.14 Nanovector s.r.l.

2.14.1 Nanovector s.r.l. Details

2.14.2 Nanovector s.r.l. Major Business

2.14.3 Nanovector s.r.l. Retinitis Pigmentosa Treatment Product and Solutions

2.14.4 Nanovector s.r.l. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Nanovector s.r.l. Recent Developments and Future Plans

2.15 Orphagen Pharmaceuticals, Inc.

2.15.1 Orphagen Pharmaceuticals, Inc. Details

2.15.2 Orphagen Pharmaceuticals, Inc. Major Business

2.15.3 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions

2.15.4 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Orphagen Pharmaceuticals, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Retinitis Pigmentosa Treatment Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Retinitis Pigmentosa Treatment Players Market Share

3.2.2 Top 10 Retinitis Pigmentosa Treatment Players Market Share

3.2.3 Market Competition Trend

3.3 Retinitis Pigmentosa Treatment Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Retinitis Pigmentosa Treatment Revenue and Market Share by Type (2016-2021)

4.2 Global Retinitis Pigmentosa Treatment Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2016-2021)

5.2 Retinitis Pigmentosa Treatment Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)

6.2 North America Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)

6.3 North America Retinitis Pigmentosa Treatment Market Size by Country

6.3.1 North America Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)

6.3.2 United States Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

6.3.3 Canada Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

6.3.4 Mexico Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)

7.2 Europe Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)

7.3 Europe Retinitis Pigmentosa Treatment Market Size by Country

7.3.1 Europe Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)

7.3.2 Germany Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

7.3.3 France Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

7.3.5 Russia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

7.3.6 Italy Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)

8.2 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)

8.3 Asia-Pacific Retinitis Pigmentosa Treatment Market Size by Region

8.3.1 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Region (2016-2026)

8.3.2 China Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

8.3.3 Japan Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

8.3.4 South Korea Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

8.3.5 India Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

8.3.7 Australia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)

9.2 South America Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)

9.3 South America Retinitis Pigmentosa Treatment Market Size by Country

9.3.1 South America Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)

9.3.2 Brazil Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

9.3.3 Argentina Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Type (2016-2026)

10.2 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Application (2016-2026)

10.3 Middle East & Africa Retinitis Pigmentosa Treatment Market Size by Country

10.3.1 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Country (2016-2026)

10.3.2 Turkey Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

10.3.4 UAE Retinitis Pigmentosa Treatment Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Retinitis Pigmentosa Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Retinitis Pigmentosa Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Retinitis Pigmentosa Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Region (2016-2021)

Table 5. Global Retinitis Pigmentosa Treatment Revenue Market Share by Region (2021-2026)

Table 6. Astellas Pharma Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Astellas Pharma Inc. Major Business

Table 8. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product and Solutions

Table 9. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Caladrius Biosciences, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Caladrius Biosciences, Inc. Major Business

Table 12. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product and Solutions

Table 13. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Dompe Farmaceutici S.p.A. Corporate Information, Head Office, and Major Competitors

Table 15. Dompe Farmaceutici S.p.A. Major Business

Table 16. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product and Solutions

Table 17. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Genable Technologies Limited Corporate Information, Head Office, and Major Competitors

Table 19. Genable Technologies Limited Major Business

Table 20. Genable Technologies Limited Retinitis Pigmentosa Treatment Product and Solutions

Table 21. Genable Technologies Limited Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Genethon Corporate Information, Head Office, and Major Competitors

Table 23. Genethon Major Business

Table 24. Genethon Retinitis Pigmentosa Treatment Product and Solutions

Table 25. Genethon Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. GenSight Biologics S.A. Corporate Information, Head Office, and Major Competitors

Table 27. GenSight Biologics S.A. Major Business

Table 28. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product and Solutions

Table 29. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Grupo Ferrer Internacional, S.A. Corporate Information, Head Office, and Major Competitors

Table 31. Grupo Ferrer Internacional, S.A. Major Business

Table 32. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product and Solutions

Table 33. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. ID Pharma Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 35. ID Pharma Co., Ltd. Major Business

Table 36. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Product and Solutions

Table 37. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. InFlectis BioScience Corporate Information, Head Office, and Major Competitors

Table 39. InFlectis BioScience Major Business

Table 40. InFlectis BioScience Retinitis Pigmentosa Treatment Product and Solutions

Table 41. InFlectis BioScience Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. International Stem Cell Corporation Corporate Information, Head Office, and Major Competitors

Table 43. International Stem Cell Corporation Major Business

Table 44. International Stem Cell Corporation Retinitis Pigmentosa Treatment Product and Solutions

Table 45. International Stem Cell Corporation Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Ionis Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Ionis Pharmaceuticals, Inc. Major Business

Table 48. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions

Table 49. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. M's Science Corporation Corporate Information, Head Office, and Major Competitors

Table 51. M's Science Corporation Major Business

Table 52. M's Science Corporation Retinitis Pigmentosa Treatment Product and Solutions

Table 53. M's Science Corporation Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Mimetogen Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors

Table 55. Mimetogen Pharmaceuticals Inc. Major Business

Table 56. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product and Solutions

Table 57. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Nanovector s.r.l. Corporate Information, Head Office, and Major Competitors

Table 59. Nanovector s.r.l. Major Business

Table 60. Nanovector s.r.l. Retinitis Pigmentosa Treatment Product and Solutions

Table 61. Nanovector s.r.l. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Orphagen Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Orphagen Pharmaceuticals, Inc. Major Business

Table 64. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions

Table 65. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Players (2019-2021)

Table 67. Global Retinitis Pigmentosa Treatment Revenue Share by Players (2019-2021)

Table 68. Breakdown of Retinitis Pigmentosa Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Retinitis Pigmentosa Treatment Players Head Office, Products and Services Provided

Table 70. Retinitis Pigmentosa Treatment Mergers & Acquisitions in the Past Five Years

Table 71. Retinitis Pigmentosa Treatment New Entrants and Expansion Plans

Table 72. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Type (2016-2021)

Table 73. Global Retinitis Pigmentosa Treatment Revenue Share by Type (2016-2021)

Table 74. Global Retinitis Pigmentosa Treatment Revenue Forecast by Type (2021-2026)

Table 75. Global Retinitis Pigmentosa Treatment Revenue by Application (2016-2021)

Table 76. Global Retinitis Pigmentosa Treatment Revenue Forecast by Application (2021-2026)

Table 77. North America Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Retinitis Pigmentosa Treatment Picture

Figure 2. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type in 2020

Figure 3. BNP-RP

Figure 4. Cenegermin

Figure 5. CPK-850

Figure 6. Cutamesine

Figure 7. FAB-111

Figure 8. Others

Figure 9. Retinitis Pigmentosa Treatment Revenue Market Share by Application in 2020

Figure 10. Hospital Picture

Figure 11. Clinic Picture

Figure 12. Homecare Picture

Figure 13. Global Retinitis Pigmentosa Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Retinitis Pigmentosa Treatment Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Retinitis Pigmentosa Treatment Revenue Market Share by Region (2016-2026)

Figure 16. Global Retinitis Pigmentosa Treatment Revenue Market Share by Region in 2020

Figure 17. North America Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Retinitis Pigmentosa Treatment Market Drivers

Figure 23. Retinitis Pigmentosa Treatment Market Restraints

Figure 24. Retinitis Pigmentosa Treatment Market Trends

Figure 25. Astellas Pharma Inc. Recent Developments and Future Plans

Figure 26. Caladrius Biosciences, Inc. Recent Developments and Future Plans

Figure 27. Dompe Farmaceutici S.p.A. Recent Developments and Future Plans

Figure 28. Genable Technologies Limited Recent Developments and Future Plans

Figure 29. Genethon Recent Developments and Future Plans

Figure 30. GenSight Biologics S.A. Recent Developments and Future Plans

Figure 31. Grupo Ferrer Internacional, S.A. Recent Developments and Future Plans

Figure 32. ID Pharma Co., Ltd. Recent Developments and Future Plans

Figure 33. InFlectis BioScience Recent Developments and Future Plans

Figure 34. International Stem Cell Corporation Recent Developments and Future Plans

Figure 35. Ionis Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 36. M's Science Corporation Recent Developments and Future Plans

Figure 37. Mimetogen Pharmaceuticals Inc. Recent Developments and Future Plans

Figure 38. Nanovector s.r.l. Recent Developments and Future Plans

Figure 39. Orphagen Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 40. Global Retinitis Pigmentosa Treatment Revenue Share by Players in 2020

Figure 41. Retinitis Pigmentosa Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 42. Global Top 3 Players Retinitis Pigmentosa Treatment Revenue Market Share in 2020

Figure 43. Global Top 10 Players Retinitis Pigmentosa Treatment Revenue Market Share in 2020

Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 45. Global Retinitis Pigmentosa Treatment Revenue Share by Type in 2020

Figure 46. Global Retinitis Pigmentosa Treatment Market Share Forecast by Type (2021-2026)

Figure 47. Global Retinitis Pigmentosa Treatment Revenue Share by Application in 2020

Figure 48. Global Retinitis Pigmentosa Treatment Market Share Forecast by Application (2021-2026)

Figure 49. North America Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)

Figure 50. North America Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)

Figure 51. North America Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)

Figure 52. United States Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Canada Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Mexico Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Europe Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)

Figure 56. Europe Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)

Figure 57. Europe Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)

Figure 58. Germany Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. France Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. United Kingdom Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Russia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Italy Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Asia-Pacific Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)

Figure 64. Asia-Pacific Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)

Figure 65. Asia-Pacific Retinitis Pigmentosa Treatment Revenue Market Share by Region (2016-2026)

Figure 66. China Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Japan Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South Korea Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. India Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Southeast Asia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Australia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. South America Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)

Figure 73. South America Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)

Figure 74. South America Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)

Figure 75. Brazil Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Argentina Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Type (2016-2026)

Figure 78. Middle East and Africa Retinitis Pigmentosa Treatment Sales Market Share by Application (2016-2026)

Figure 79. Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Country (2016-2026)

Figure 80. Turkey Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Saudi Arabia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. UAE Retinitis Pigmentosa Treatment Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Methodology

Figure 84. Research Process and Data Source